Literature DB >> 23657630

In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1.

Shruti D Dave1, Aruna V Vanikar, Hargovind L Trivedi.   

Abstract

We present a study of up-regulation of genes responsible for pancreatic development in glucose-sensitive insulin-secreting mesenchymal stem cells (IS-MSC) generated and differentiated from human adipose tissue (h-AD), with use of our specific differentiation media and without use of any xenogenic material. Anterior wall abdominal fat was collected from 56 volunteers and cultured in self-designed proliferation medium for 10 days. Cells were harvested by trypsinization and differentiated into insulin-expressing cells using self-designed differentiation medium for 3 days followed by evaluation for transcriptional factors Pax-6, Ipf-1, Isl-1, C-peptide and insulin secretion. Generated IS-MSC showed expression of Pax-6, Pdx-6 and Isl-1. Non-differentiated MSC as well as their further culture in absence of differentiation medium were used as negative controls. Generated 56 IS-MSC cell-lines were glucose responsive i.e. mean C-Peptide and insulin secretion levels were measured 0.41 ng/ml and 13.13 μU/ml, respectively, in absence of glucose which rose to 1.18 ng/ml and 83.42 μU/ml, respectively, following glucose challenge (p < 0.001). The mean rise in C-peptide and insulin secretion levels was 2.88 and 6.35 fold, respectively. To conclude insulin-secreting h-AD-MSC can be generated safely and effectively with application of specific differentiation media without xenogeneic material/any genetic modification, showing expression of transcriptional factors Pax-6, Ipf-1 and Isl-1.

Entities:  

Year:  2013        PMID: 23657630      PMCID: PMC3918267          DOI: 10.1007/s10616-013-9573-3

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

1.  Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development.

Authors:  M Sander; A Neubüser; J Kalamaras; H C Ee; G R Martin; M S German
Journal:  Genes Dev       Date:  1997-07-01       Impact factor: 11.361

2.  Localization of human homeodomain transcription factor insulin promoter factor 1 (IPF1) to chromosome band 13q12.1.

Authors:  M Stoffel; R Stein; C V Wright; R Espinosa; M M Le Beau; G I Bell
Journal:  Genomics       Date:  1995-07-01       Impact factor: 5.736

3.  Activation of dormant genes in specialized cells.

Authors:  M A DiBerardino; N J Hoffner; L D Etkin
Journal:  Science       Date:  1984-06-01       Impact factor: 47.728

4.  Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas.

Authors:  L St-Onge; B Sosa-Pineda; K Chowdhury; A Mansouri; P Gruss
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

5.  Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow.

Authors:  Lin Song; Rocky S Tuan
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

6.  Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.

Authors:  Yuichi Hori; Ingrid C Rulifson; Bernette C Tsai; Jeremy J Heit; John D Cahoy; Seung K Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

7.  Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells.

Authors:  Li-Bo Chen; Xiao-Bing Jiang; Lian Yang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates.

Authors:  Anandwardhan A Hardikar; Bernice Marcus-Samuels; Elizabeth Geras-Raaka; Bruce M Raaka; Marvin C Gershengorn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

9.  Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.

Authors:  H L Trivedi; A V Vanikar; U Thakker; A Firoze; S D Dave; C N Patel; J V Patel; A B Bhargava; V Shankar
Journal:  Transplant Proc       Date:  2008-05       Impact factor: 1.066

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  6 in total

1.  Investigating the mincing method for isolation of adipose-derived stem cells from pregnant women fat.

Authors:  Yuan-Sheng Li; Pao-Jen Chen; Li-Wei Wu; Pei-Wen Chou; Li-Yi Sun; Tzyy-Wen Chiou
Journal:  Cytotechnology       Date:  2017-12-12       Impact factor: 2.058

2.  Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells.

Authors:  Kamal Shaik Fakiruddin; Puteri Baharuddin; Moon Nian Lim; Noor Atiqah Fakharuzi; Nurul Ain Nasim M Yusof; Zubaidah Zakaria
Journal:  Cancer Cell Int       Date:  2014-11-26       Impact factor: 5.722

Review 3.  Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes.

Authors:  Yicheng Qi; Jing Ma; Shengxian Li; Wei Liu
Journal:  Stem Cell Res Ther       Date:  2019-08-28       Impact factor: 6.832

Review 4.  Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application.

Authors:  Simona Ceccarelli; Paola Pontecorvi; Eleni Anastasiadou; Claudio Napoli; Cinzia Marchese
Journal:  Front Cell Dev Biol       Date:  2020-04-17

Review 5.  Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells.

Authors:  Nadine E Rekittke; Meidjie Ang; Divya Rawat; Rahul Khatri; Thomas Linn
Journal:  Stem Cells Int       Date:  2016-03-07       Impact factor: 5.443

6.  Antioxidative Capacity of Liver- and Adipose-Derived Mesenchymal Stem Cell-Conditioned Media and Their Applicability in Treatment of Type 2 Diabetic Rats.

Authors:  Mohamed M Elshemy; Medhat Asem; Khaled S Allemailem; Koichiro Uto; Mitsuhiro Ebara; Ahmed Nabil
Journal:  Oxid Med Cell Longev       Date:  2021-02-02       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.